227 related articles for article (PubMed ID: 30698038)
21. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
[TBL] [Abstract][Full Text] [Related]
22. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
Gerdts E; Cramariuc D; de Simone G; Wachtell K; Dahlöf B; Devereux RB
Eur J Echocardiogr; 2008 Nov; 9(6):809-15. PubMed ID: 18490279
[TBL] [Abstract][Full Text] [Related]
23. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiographic prediction of left ventricular hypertrophy in women and men with left bundle branch block - Comparison of QRS duration, amplitude and voltage-time-integral.
DeBauge A; Fairbank T; Harvey CJ; Ranka S; Jiwani S; Sheldon SH; Reddy M; Beaver TA; Noheria A
J Electrocardiol; 2023; 80():34-39. PubMed ID: 37178633
[TBL] [Abstract][Full Text] [Related]
25. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
26. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
27. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
28. Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.
Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Shimizu W
Heart Rhythm; 2014 May; 11(5):836-41. PubMed ID: 24561161
[TBL] [Abstract][Full Text] [Related]
29. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.
Morin DP; Oikarinen L; Viitasalo M; Toivonen L; Nieminen MS; Kjeldsen SE; Dahlöf B; John M; Devereux RB; Okin PM
Eur Heart J; 2009 Dec; 30(23):2908-14. PubMed ID: 19687165
[TBL] [Abstract][Full Text] [Related]
30. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
31. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
32. Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; Bella JN; Gerdts E; Wachtell K; Gardin J; Papademetriou V; Nieminen MS; Dahlöf B; Devereux RB;
Hypertension; 2003 Jan; 41(1):75-82. PubMed ID: 12511533
[TBL] [Abstract][Full Text] [Related]
33. The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: a multicenter study.
Pope JH; Ruthazer R; Kontos MC; Beshansky JR; Griffith JL; Selker HP
Am J Emerg Med; 2004 May; 22(3):156-63. PubMed ID: 15138949
[TBL] [Abstract][Full Text] [Related]
34. Etiology and Left Ventricular Functions in Left Bundle Branch Block- A Prospective Observational Study.
Bhardwaj R
J Assoc Physicians India; 2016 Sep; 64(9):36-38. PubMed ID: 27762513
[TBL] [Abstract][Full Text] [Related]
35. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
36. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
37. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
[TBL] [Abstract][Full Text] [Related]
38. Association between electrocardiographic left ventricular hypertrophy with strain pattern and left ventricular structure and function.
Ogah OS; Adebiyi AA; Oladapo OO; Aje A; Ojji DB; Adebayo AK; Salako BL; Falase AO
Cardiology; 2006; 106(1):14-21. PubMed ID: 16601328
[TBL] [Abstract][Full Text] [Related]
39. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study.
Wang NC; Singh M; Adelstein EC; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S
Heart Rhythm; 2016 Apr; 13(4):933-42. PubMed ID: 26688064
[TBL] [Abstract][Full Text] [Related]
40. Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study.
Ariansen I; Reims HM; Gjesdal K; Olsen MH; Ibsen H; Devereux RB; Okin PM; Kjeldsen SE; Dahlöf B; Wachtell K
Blood Press; 2012 Feb; 21(1):6-11. PubMed ID: 22070095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
